1.23
price up icon1.65%   0.02
after-market アフターアワーズ: 1.24 0.01 +0.81%
loading
前日終値:
$1.21
開ける:
$1.2
24時間の取引高:
561.87K
Relative Volume:
0.96
時価総額:
$76.16M
収益:
$248.00K
当期純損益:
$-149.34M
株価収益率:
-0.5052
EPS:
-2.4348
ネットキャッシュフロー:
$-128.71M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
-6.11%
6か月 パフォーマンス:
-19.61%
1年 パフォーマンス:
-13.99%
1日の値動き範囲:
Value
$1.20
$1.26
1週間の範囲:
Value
$1.19
$1.26
52週間の値動き範囲:
Value
$1.09
$1.95

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
名前
Pliant Therapeutics Inc
Name
セクター
Healthcare (1111)
Name
電話
650-481-6770
Name
住所
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
職員
49
Name
Twitter
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
PLRX's Discussions on Twitter

Compare PLRX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PLRX icon
PLRX
Pliant Therapeutics Inc
1.23 74.92M 248.00K -149.34M -128.71M -2.4348
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
427.65 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
721.05 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
807.55 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
303.00 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
313.32 33.06B 5.36B 287.73M 924.18M 2.5229

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 ダウングレード JP Morgan Neutral → Underweight
2025-03-04 再開されました Cantor Fitzgerald Neutral
2025-03-04 ダウングレード Needham Buy → Hold
2025-03-03 ダウングレード Leerink Partners Outperform → Market Perform
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-10 ダウングレード Canaccord Genuity Buy → Hold
2025-02-10 ダウングレード Citigroup Buy → Neutral
2025-02-10 ダウングレード H.C. Wainwright Buy → Neutral
2025-02-10 ダウングレード JP Morgan Overweight → Neutral
2025-02-10 ダウングレード Oppenheimer Outperform → Perform
2025-02-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-10 ダウングレード Wells Fargo Overweight → Equal Weight
2024-09-09 再開されました Leerink Partners Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-05-18 開始されました Canaccord Genuity Buy
2023-04-13 開始されました Robert W. Baird Outperform
2022-12-14 開始されました Stifel Buy
2022-12-07 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Buy
2022-07-20 開始されました SVB Leerink Outperform
2022-05-25 開始されました Cantor Fitzgerald Overweight
2021-12-10 開始されました Oppenheimer Outperform
2021-11-24 開始されました RBC Capital Mkts Outperform
2021-11-03 開始されました H.C. Wainwright Buy
2021-04-20 開始されました BTIG Research Buy
2021-04-05 開始されました Citigroup Buy
2020-06-29 開始されました Citigroup Buy
2020-06-29 開始されました Cowen Outperform
2020-06-29 開始されました Needham Buy
2020-06-29 開始されました Piper Sandler Overweight
すべてを表示

Pliant Therapeutics Inc (PLRX) 最新ニュース

pulisher
08:42 AM

Pliant CEO, CFO to join RBC healthcare fireside chat on May 19 - Stock Titan

08:42 AM
pulisher
08:30 AM

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - Yahoo Finance

08:30 AM
pulisher
May 04, 2026

PLRX SEC FilingsPliant Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Pliant Therapeutics Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView

May 04, 2026
pulisher
May 03, 2026

Pliant Therapeutics (NASDAQ:PLRX) Upgraded at Wall Street Zen - MarketBeat

May 03, 2026
pulisher
Apr 30, 2026

Pliant Therapeutics (PLRX) Initiates Key Clinical Trial for Canc - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors - Investing News Network

Apr 30, 2026
pulisher
Apr 30, 2026

Pliant Therapeutics begins trial of cancer drug combination By Investing.com - Investing.com South Africa

Apr 30, 2026
pulisher
Apr 30, 2026

Pliant Therapeutics begins trial of cancer drug combination - Investing.com

Apr 30, 2026
pulisher
Apr 30, 2026

New cancer trial starts for patients after immunotherapy stops working - Stock Titan

Apr 30, 2026
pulisher
Apr 27, 2026

Pliant Therapeutics (PLRX) price target decreased by 17.95% to 2.72 - MSN

Apr 27, 2026
pulisher
Apr 25, 2026

Pliant Therapeutics Inc (FRA:9PT) Stock Price & 30 Year Financial Data - GuruFocus

Apr 25, 2026
pulisher
Apr 25, 2026

Wall Street Zen Downgrades Pliant Therapeutics (NASDAQ:PLRX) to Sell - MarketBeat

Apr 25, 2026
pulisher
Apr 22, 2026

Pliant Therapeutics (NASDAQ: PLRX) outlines 2026 virtual meeting, board changes and pay vote - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

[ARS] PLIANT THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 22, 2026
pulisher
Apr 21, 2026

Pliant Therapeutics, Inc. (PLRX) Presents at AACR Annual Meeting 2026Slideshow (NASDAQ:PLRX) 2026-04-21 - Seeking Alpha

Apr 21, 2026
pulisher
Apr 20, 2026

Primary Sclerosing Cholangitis (PSC) Market is expected to Hit - openPR.com

Apr 20, 2026
pulisher
Apr 19, 2026

Pliant Therapeutics (PLRX) Reports Promising Updates on PLN-101095 Trials - GuruFocus

Apr 19, 2026
pulisher
Apr 19, 2026

Pliant Therapeutics (PLRX) Reports Promising Updates on PLN-1010 - GuruFocus

Apr 19, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics (PLRX) Stock: Movement Analysis (Breakout Watch) 2026-04-18Elite Trading Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant presents updated cancer trial data at AACR meeting By Investing.com - Investing.com South Africa

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics presents updated Phase 1 data for PLN-101095 in ICI-refractory tumors - Traders Union

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant presents updated cancer trial data at AACR meeting - Investing.com

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics : Final AACR 2026 PLN10195 Yap - marketscreener.com

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics Says Pln-101095 Generally Well Tolerated; Most Common Trae Was Rash, One Grade 3 Trae Observed - TradingView

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics Announces Presentation of Updated Data - GlobeNewswire

Apr 18, 2026
pulisher
Apr 18, 2026

Pliant Therapeutics, Inc. 8-K SEC Filing Details for April 14, 2026 – Company Information, Registered Securities, and NASDAQ Listing - Minichart

Apr 18, 2026
pulisher
Apr 17, 2026

Pliant Therapeutics Announces Board Retirements and Option Repricing - TipRanks

Apr 17, 2026
pulisher
Apr 17, 2026

COO Minnie Kuo’s PLRX options repriced to $1.33 exercise price (PLRX) - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

Form 4Statement of changes in beneficial ownership of securities - ADVFN

Apr 17, 2026
pulisher
Apr 17, 2026

PLIANT THERAPEUTICS (PLRX) reprices Lily Cheung stock options at $1.33 - Stock Titan

Apr 17, 2026
pulisher
Apr 17, 2026

Form 8-KCurrent report - ADVFN

Apr 17, 2026
pulisher
Apr 17, 2026

Pliant Therapeutics (PLRX) CEO resets multiple option grants to $1.33 - Stock Titan

Apr 17, 2026
pulisher
Apr 15, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat

Apr 15, 2026
pulisher
Apr 14, 2026

Pliant Therapeutics (NASDAQ:PLRX) Shares Up 1.6%Should You Buy? - MarketBeat

Apr 14, 2026
pulisher
Apr 13, 2026

If You Invested $1,000 in Pliant Therapeutics, Inc. (PLRX) - Stock Titan

Apr 13, 2026
pulisher
Apr 13, 2026

Bull Run: Is Pliant Therapeutics Inc subject to activist investor interest2026 Catalysts & High Conviction Buy Zone Picks - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

Inflation Data: Is Pliant Therapeutics Inc still a buy after recent gainsPortfolio Update Report & Technical Confirmation Trade Alerts - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 10, 2026

PLRX Technical Analysis | Trend, Signals & Chart Patterns | PLIANT THERAPEUTICS INC (NASDAQ:PLRX) - ChartMill

Apr 10, 2026
pulisher
Apr 07, 2026

[EFFECT] PLIANT THERAPEUTICS, INC. SEC Filing - Stock Titan

Apr 07, 2026
pulisher
Apr 06, 2026

Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Apr 06, 2026
pulisher
Apr 06, 2026

Is Pliant Therapeutics (PLRX) Stock Lagging the Market | Price at $1.36, Up 0.74%Theta Decay - Xã Vĩnh Công

Apr 06, 2026
pulisher
Apr 05, 2026

Live Pliant Therapeutics, Inc. (PLRX) Technical Analysis - Traders Union

Apr 05, 2026
pulisher
Apr 05, 2026

Pliant Therapeutics (PLRX) Stock Analysis Report | Financials & Insights - Benzinga Japan

Apr 05, 2026
pulisher
Apr 04, 2026

PLRX PE Ratio & Valuation, Is PLRX Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction for 2026, 2030-2040 - tradersunion.com

Apr 04, 2026
pulisher
Apr 02, 2026

PLRX Stock Analysis: Pliant Therapeutics Inc. gains 3.53 percent at 1.32 dollar price point - Newser

Apr 02, 2026

Pliant Therapeutics Inc (PLRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.82
price up icon 1.77%
$50.72
price up icon 0.56%
$95.26
price down icon 0.25%
$137.09
price down icon 1.69%
$151.07
price up icon 2.62%
ONC ONC
$313.32
price up icon 5.32%
大文字化:     |  ボリューム (24 時間):